Imaging of an Indeterminate Pancreatic Mass

Abstract

Several conditions ranging from neoplasm to inflammatory disorders can present as a pancreatic mass on imaging. While classic imaging features help us make an accurate diagnosis, we are often confronted by indeterminate pancreatic masses that pose diagnostic dilemma. In this review, we describe the typical imaging features of common mass forming conditions of pancreas followed by description of atypical imaging appearances, which make a pancreatic mass indeterminate. We also emphasize on imaging features useful in differentiating one from the other.

Keywords

CT - MRI - EUS - imaging - pancreatic masses - indeterminate

Publication History

Article published online:
06 March 2020

• References

• 1 de la Santa LG, Retortillo JAP, Miguel AC, Klein LM. Radiology of pancreatic neoplasms: an update. World J Gastrointest Oncol 2014; 6 (09) 330-343
• 2 Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol 2014; 20 (24) 7864-7877
• 3 Gandhi NS, Feldman MK, Le O, Morris-Stiff G. Imaging mimics of pancreatic ductal adenocarcinoma. Abdom Radiol (NY) 2018; 43 (02) 273-284
• 4 Adsay NV, Basturk O, Klimstra DS, Klöppel G. Pancreatic pseudotumors: non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer. Semin Diagn Pathol 2004; 21 (04) 260-267
• 5 Abraham SC, Wilentz RE, Yeo CJ. et al. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all ‘chronic pancreatitis’?. Am J Surg Pathol 2003; 27 (01) 110-120
• 6 Shrikhande SV, Barreto SG, Goel M, Arya S. Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literature. HPB (Oxford) 2012; 14 (10) 658-668
• 7 Brennan DDD, Zamboni GA, Raptopoulos VD, Kruskal JB. Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT. Radiographics 2007; 27 (06) 1653-1666
• 8 Zaky AM, Wolfgang CL, Weiss MJ, Javed AA, Fishman EK, Zaheer A. Tumor-vessel relationships in pancreatic ductal adenocarcinoma at multidetector CT: different classification systems and their influence on treatment planning. Radiographics 2017; 37 (01) 93-112
• 9 Raman SP, Salaria SN, Hruban RH, Fishman EK. Groove pancreatitis: spectrum of imaging findings and radiology-pathology correlation. AJR Am J Roentgenol 2013; 201 (01) W29-39
• 10 Vortmeyer AO, Huang S, Lubensky I, Zhuang Z. Non-islet origin of pancreatic islet cell tumors. J Clin Endocrinol Metab 2004; 89 (04) 1934-1938
• 11 Humphrey PE, Alessandrino F, Bellizzi AM, Mortele KJ. Non-hyperfunctioning pancreatic endocrine tumors: multimodality imaging features with histopathological correlation. Abdom Imaging 2015; 40 (07) 2398-2410
• 12 Lewis RB, Lattin Jr GE, Paal E. Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 2010; 30 (06) 1445-1464
• 13 Raman SP, Hruban RH, Cameron JL, Wolfgang CL, Fishman EK. Pancreatic imaging mimics: part 2, pancreatic neuroendocrine tumors and their mimics. AJR Am J Roentgenol 2012; 199 (02) 309-318
• 14 Jeon SK, Lee JM, Joo I. et al. Nonhypervascular pancreatic neuroendocrine tumors: differential diagnosis from pancreatic ductal adenocarcinomas at MR imaging-retrospective cross-sectional study. Radiology 2017; 284 (01) 77-87
• 15 Geijer H, Breimer LH. Somatostatin receptor PET/CT in neuroendocrine tumours: update on systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2013; 40 (11) 1770-1780
• 16 Hofman MS, Kong G, Neels OC, Eu P, Hong E, Hicks RJ. High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours. J Med Imaging Radiat Oncol 2012; 56 (01) 40-47
• 17 Poultsides GA, Huang LC, Chen Y. et al. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol 2012; 19 (07) 2295-2303
• 18 Ahmed S, Johnson PT, Hruban R, Fishman EK. Metastatic disease to the pancreas: pathologic spectrum and CT patterns. Abdom Imaging 2013; 38 (01) 144-153
• 19 Sweeney AD, Fisher WE, Wu M-F, Hilsenbeck SG, Brunicardi FC. Value of pancreatic resection for cancer metastatic to the pancreas. J Surg Res 2010; 160 (02) 268-276
• 20 Klein KA, Stephens DH, Welch TJ. CT characteristics of metastatic disease of the pancreas. Radiographics 1998; 18 (02) 369-378
• 21 Ascenti G, Visalli C, Genitori A, Certo A, Pitrone A, Mazziotti S. Multiple hypervascular pancreatic metastases from renal cell carcinoma: dynamic MR and spiral CT in three cases. Clin Imaging 2004; 28 (05) 349-352
• 22 Coakley FV, Hanley-Knutson K, Mongan J, Barajas R, Bucknor M, Qayyum A. Pancreatic imaging mimics: part 1, imaging mimics of pancreatic adenocarcinoma. AJR Am J Roentgenol 2012; 199 (02) 301-308
• 23 Merkle EM, Bender GN, Brambs H-J. Imaging findings in pancreatic lymphoma: differential aspects. AJR Am J Roentgenol 2000; 174 (03) 671-675
• 24 Khandelwal A, Shanbhogue AK, Takahashi N, Sandrasegaran K, Prasad SR. Recent advances in the diagnosis and management of autoimmune pancreatitis. AJR Am J Roentgenol 2014; 202 (05) 1007-1021
• 25 Shimosegawa T, Chari ST, Frulloni L. et al. International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011; 40 (03) 352-358
• 26 Bodily KD, Takahashi N, Fletcher JG. et al. Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings. AJR Am J Roentgenol 2009; 192 (02) 431-437
• 27 Lee-Felker SA, Felker ER, Kadell B. et al. Use of MDCT to differentiate autoimmune pancreatitis from ductal adenocarcinoma and interstitial pancreatitis. AJR Am J Roentgenol 2015; 205 (01) 2-9
• 28 Takahashi N, Fletcher JG, Hough DM. et al. Autoimmune pancreatitis: differentiation from pancreatic carcinoma and normal pancreas on the basis of enhancement characteristics at dual-phase CT. AJR Am J Roentgenol 2009; 193 (02) 479-484
• 29 Hur BY, Lee JM, Lee JE. et al. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. J Magn Reson Imaging 2012; 36 (01) 188-197
• 30 Muhi A, Ichikawa T, Motosugi U. et al. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging 2012; 35 (04) 827-836
• 31 Kamisawa T, Takuma K, Anjiki H. et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol 2010; 105 (08) 1870-1875
• 32 Sun G-F, Zuo C-J, Shao C-W, Wang J-H, Zhang J. Focal autoimmune pancreatitis: radiological characteristics help to distinguish from pancreatic cancer. World J Gastroenterol 2013; 19 (23) 3634-3641
• 33 Ichikawa T, Sou H, Araki T. et al. Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 2001; 221 (01) 107-116
• 34 Blasbalg R, Baroni RH, Costa DN, Machado MCC. MRI features of groove pancreatitis. AJR Am J Roentgenol 2007; 189 (01) 73-80
• 35 Mittal PK, Harri P, Nandwana S. et al. Paraduodenal pancreatitis: benign and malignant mimics at MRI. Abdom Radiol (NY) 2017; 42 (11) 2652-2674
• 36 Ishigami K, Tajima T, Nishie A. et al. Differential diagnosis of groove pancreatic carcinomas vs. groove pancreatitis: usefulness of the portal venous phase. Eur J Radiol 2010; 74 (03) e95-e100
• 37 Ahualli J. The double duct sign. Radiology 2007; 244 (01) 314-315
• 38 Pramesh CS, Heroor AA, Gupta SG. et al. Pancreatic tuberculosis: an elusive diagnosis. HPB (Oxford) 2003; 5 (01) 43-45
• 39 Rao RN, Pandey R, Rana MK, Rai P, Gupta A. Pancreatic and peripancreatic tuberculosis presenting as hypoechoic mass and malignancy diagnosed by ultrasound-guided fine-needle aspiration cytology. J Cytol 2013; 30 (02) 130-135